Vivos therapeutics schedules release of third quarter 2023 financial results and conference call

Littleton, colo., nov. 09, 2023 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company”) (nasdaq: vvos), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (osa) and snoring in adults, today announced it plans to release its third quarter 2023 financial results after market close on tuesday, november 14, 2023.
VVOS Ratings Summary
VVOS Quant Ranking